GHV Infra Projects Fund Raise of ₹154 Cr

GHV Infra Projects Results Update

GHV Infra Projects reports Q2 FY27 revenue of ₹300 Cr and PAT of ₹18 Cr. H1 order intake of ₹10,334 Cr lifts backlog to ₹19,094 Cr.

GHV Infra Projects Q2 FY27 Results: Net Profit ₹17.4 Cr, Up 135.1% QoQ

GHV Infra Projects Ltd reported revenue from operations of ₹300.1 Cr and net profit of ₹17.4 Cr for Q2 FY27.

Key figure

Net profit ₹17.4 Cr

GHV Infra Projects Other Announcement

The company filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026, detailing promoter and public shareholding.

GHV Infra Projects Management Change

GHV Infra Projects Limited announced the resignation of Mr. Sadanand Shetty from his position as Chief Financial Officer and Key Managerial Personnel, effective October 21, 2026.

GHV Infra Projects Board Meeting Date

GHV Infra Projects Limited has scheduled a board meeting for October 22, 2026, to consider and approve the unaudited standalone and consolidated financial results.

GHV Infra Projects Promoter Reclassification

GHV Infra Projects Limited announced shareholders approved the reclassification of Husena A. Musamji from the Promoter and Promoter Group category to the Public category at the 49th AGM.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.